Annual Total Long Term Liabilities
$1.48 M
+$1.48 M+100.00%
31 December 2023
Summary:
Oncternal Therapeutics annual total long term liabilities is currently $1.48 million, with the most recent change of +$1.48 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.48 million (+100.00%). ONCT annual total long term liabilities is now -99.11% below its all-time high of $165.29 million, reached on 31 December 2003.ONCT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
-$50.00 K-100.00%
30 September 2024
Summary:
Oncternal Therapeutics quarterly total long term liabilities is currently $0.00, with the most recent change of -$50.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$1.05 million (-100.00%). ONCT quarterly long term liabilities is now -100.00% below its all-time high of $165.29 million, reached on 31 December 2003.ONCT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | +100.0% | 0.0% |
| 5 y5 years | +100.0% | -100.0% |
ONCT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | ||
| 5 y | 5 years | at high | -100.0% | ||
| alltime | all time | -99.1% | -100.0% |
Oncternal Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) |
| June 2024 | - | $50.00 K(-49.5%) |
| Mar 2024 | - | $99.00 K(-93.3%) |
| Dec 2023 | $1.48 M(>+9900.0%) | $1.48 M(+41.3%) |
| Sept 2023 | - | $1.05 M(+38.1%) |
| June 2023 | - | $758.00 K(+147.7%) |
| Mar 2023 | - | $306.00 K(>+9900.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(-100.0%) |
| June 2022 | - | $13.00 K(>+9900.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $31.00 K(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $301.00 K(0.0%) |
| June 2020 | - | $301.00 K(+467.9%) |
| Mar 2020 | - | $53.00 K(-41.8%) |
| Dec 2019 | $91.00 K(>+9900.0%) | $91.00 K(-29.5%) |
| Sept 2019 | - | $129.00 K(+2.4%) |
| June 2019 | - | $126.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $20.00 K(-33.3%) |
| Dec 2014 | $30.00 K(-91.5%) | $30.00 K(-63.4%) |
| Sept 2014 | - | $82.00 K(-44.2%) |
| June 2014 | - | $147.00 K(-24.6%) |
| Mar 2014 | - | $195.00 K(-44.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $354.00 K(-38.8%) | $354.00 K(-9.0%) |
| Sept 2013 | - | $389.00 K(-10.8%) |
| June 2013 | - | $436.00 K(-10.7%) |
| Mar 2013 | - | $488.00 K(-15.6%) |
| Dec 2012 | $578.00 K(-39.1%) | $578.00 K(-26.5%) |
| Sept 2012 | - | $786.00 K(+200.0%) |
| June 2012 | - | $262.00 K(+11.5%) |
| Mar 2012 | - | $235.00 K(-75.2%) |
| Dec 2011 | $949.00 K(-86.9%) | $949.00 K(+295.4%) |
| Sept 2011 | - | $240.00 K(+10.6%) |
| June 2011 | - | $217.00 K(-11.8%) |
| Mar 2011 | - | $246.00 K(-96.6%) |
| Dec 2010 | $7.22 M(-85.7%) | $7.22 M(-5.0%) |
| Sept 2010 | - | $7.60 M(-4.9%) |
| June 2010 | - | $7.99 M(+33.4%) |
| Mar 2010 | - | $5.99 M(-88.1%) |
| Dec 2009 | $50.52 M(-8.3%) | $50.52 M(+8.4%) |
| Sept 2009 | - | $46.61 M(-5.8%) |
| June 2009 | - | $49.47 M(-5.3%) |
| Mar 2009 | - | $52.24 M(-5.2%) |
| Dec 2008 | $55.11 M(-10.4%) | $55.11 M(+3.6%) |
| Sept 2008 | - | $53.22 M(-4.9%) |
| June 2008 | - | $55.97 M(-4.7%) |
| Mar 2008 | - | $58.73 M(-4.5%) |
| Dec 2007 | $61.48 M(+181.1%) | $61.48 M(+252.9%) |
| Sept 2007 | - | $17.42 M(-7.9%) |
| June 2007 | - | $18.90 M(-7.3%) |
| Mar 2007 | - | $20.39 M(-6.8%) |
| Dec 2006 | $21.87 M(+571.2%) | $21.87 M(-13.6%) |
| Sept 2006 | - | $25.31 M(+857.1%) |
| June 2006 | - | $2.64 M(-12.2%) |
| Mar 2006 | - | $3.01 M(-7.5%) |
| Dec 2005 | $3.26 M(-24.6%) | $3.26 M(-1.6%) |
| Sept 2005 | - | $3.31 M(-9.2%) |
| June 2005 | - | $3.65 M(-8.4%) |
| Mar 2005 | - | $3.98 M(-7.8%) |
| Dec 2004 | $4.32 M(-97.4%) | $4.32 M(-6.7%) |
| Sept 2004 | - | $4.63 M(-6.7%) |
| June 2004 | - | $4.96 M(-6.3%) |
| Mar 2004 | - | $5.30 M(-96.8%) |
| Dec 2003 | $165.29 M(+158.2%) | $165.29 M |
| Dec 2002 | $64.03 M(+129.4%) | - |
| Dec 2000 | $27.91 M(+1714.8%) | - |
| Dec 1999 | $1.54 M | - |
FAQ
- What is Oncternal Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual total long term liabilities year-on-year change?
- What is Oncternal Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly long term liabilities year-on-year change?
What is Oncternal Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ONCT is $1.48 M
What is the all time high annual total long term liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total long term liabilities is $165.29 M
What is Oncternal Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ONCT annual total long term liabilities has changed by +$1.48 M (+100.00%)
What is Oncternal Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ONCT is $0.00
What is the all time high quarterly long term liabilities for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total long term liabilities is $165.29 M
What is Oncternal Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ONCT quarterly total long term liabilities has changed by -$1.05 M (-100.00%)